We plan to continue expanding our footprints in India, including producing quality excipients and introducing new products Read more
Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry Read more
Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe Read more